Remove Gene Therapy Remove In-Vitro Remove Reagent
article thumbnail

US: BioIVT acquires serum, plasma and reagent producer

BioPharma Reporter

The New York based company said the deal will expand its in vitro diagnostic, cell and gene therapy support capabilities.

Reagent 52
article thumbnail

Top 30 New Medical Devices of 2024

XTalks

Abbotts SCS devices deliver its proprietary BurstDR stimulation waveform, a superior therapy designed to more closely mimic how pain signals travel to the brain and treat the emotional suffering related to pain. In this process, the sample is mixed with specific test chemicals.

article thumbnail

Top 10 Biotech Trends for 2025

XTalks

For example, antisense oligonucleotide (ASO)-based therapies have gained traction, with 100 Phase I clinical trials initiated and around 25 percent of these advancing to Phase II or Phase III trials in recent years. Related: Biotech IPOs in 2024: Navigating the New Wave of Innovation 1.